Autolus Therapeutics (AUTL) EBIT Margin (2017 - 2025)
Autolus Therapeutics posted quarterly EBIT Margin of 298.35% for Q4 2025, up 26130165.0% year-on-year from N/an in Q4 2024, and up 11.71% on a QoQ basis from 337.93% in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of EBIT Margin data on file, last reported at 298.35% in Q4 2025.
- For the quarter ending Q4 2025, EBIT Margin rose 26130165.0% year-over-year to 298.35%; the trailing twelve-month figure through Dec 2025 stood at 358.87% (up 202464.0% YoY), and the FY2025 full-year result was 358.87%, up 202676.0% from the prior year.
- EBIT Margin for Q4 2025 stood at 298.35%, up from 337.93% in the prior quarter.
- Across five years, EBIT Margin topped out at 1937.51% in Q4 2021 and bottomed at 16684745.76% in Q3 2021.
- The 5-year median for EBIT Margin is 2623.09% (2021), against an average of 1307612.4%.
- The widest annual swing landed in 2021, when EBIT Margin slumped 1667443069 bps; it then soared 26130165 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 1937.51% in 2021, then sank by 1225 bps to 21798.8% in 2022, then jumped by 52 bps to 10567.73% in 2023, then slumped by 2375 bps to 261600.0% in 2024, then surged by 100 bps to 298.35% in 2025.
- The last three EBIT Margin figures came in at 298.35% (Q4 2025), 337.93% (Q3 2025), and 292.58% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 38.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 17.83% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 23.02% |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -298.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -298.35% |
| Sep 30, 2025 | -337.93% |
| Jun 30, 2025 | -292.58% |
| Mar 31, 2025 | -726.34% |
| Dec 31, 2024 | -261,600.00% |
| Mar 31, 2024 | -383.73% |
| Sep 30, 2023 | -10,567.73% |
| Mar 31, 2023 | -3,030.03% |
| Mar 31, 2022 | -21,798.80% |
| Dec 31, 2021 | 1,937.51% |
| Sep 30, 2021 | -16,684,745.76% |
| Jun 30, 2021 | -2,623.09% |
| Mar 31, 2021 | -14,494.42% |
| Dec 31, 2020 | -11,990.59% |
| Sep 30, 2020 | -10,315.07% |
| Jun 30, 2020 | -13,333.11% |
| Mar 31, 2020 | -9,931.66% |
| Dec 31, 2017 | -3,861.90% |